8942896

Source:http://linkedlifedata.com/resource/pubmed/id/8942896

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0282461, umls-concept:C0392265, umls-concept:C0395416, umls-concept:C1257890, umls-concept:C1274040, umls-concept:C1521970
pubmed:issue	11
pubmed:dateCreated	1996-12-20
pubmed:abstractText	To identify preoperative and intraoperative characteristics associated with outcomes of photorefractive keratectomy (PRK).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7802443
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0161-6420
pubmed:author	pubmed-author:HershP SPS, pubmed-author:ScheinO DOD, pubmed-author:SteinertRR
pubmed:issnType	Print
pubmed:volume	103
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1962-9
pubmed:dateRevised	2008-11-21
pubmed:meshHeading	pubmed-meshheading:8942896-Adult, pubmed-meshheading:8942896-Astigmatism, pubmed-meshheading:8942896-Cohort Studies, pubmed-meshheading:8942896-Cornea, pubmed-meshheading:8942896-Female, pubmed-meshheading:8942896-Humans, pubmed-meshheading:8942896-Lasers, Excimer, pubmed-meshheading:8942896-Male, pubmed-meshheading:8942896-Middle Aged, pubmed-meshheading:8942896-Myopia, pubmed-meshheading:8942896-Photorefractive Keratectomy, pubmed-meshheading:8942896-Predictive Value of Tests, pubmed-meshheading:8942896-Refraction, Ocular, pubmed-meshheading:8942896-Regression Analysis, pubmed-meshheading:8942896-Treatment Outcome, pubmed-meshheading:8942896-Visual Acuity
pubmed:year	1996
pubmed:articleTitle	Characteristics influencing outcomes of excimer laser photorefractive keratectomy. Summit Photorefractive Keratectomy Phase III Study Group.
pubmed:affiliation	Department of Ophthalmology, UMDNJ-New Jersey Medical School, Newark, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III